288330 — Bridge Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩59bn
- KR₩42bn
- KR₩2m
Annual cashflow statement for Bridge Biotherapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19,232 | -26,278 | -41,700 | -42,455 | -19,933 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1,206 | 2,949 | 1,415 | 4,819 | 1,189 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4,632 | 1,820 | -976 | 4,437 | -3,403 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -13,037 | -21,128 | -40,182 | -31,775 | -20,715 |
| Capital Expenditures | -79.8 | -169 | -438 | -369 | -140 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -31,774 | 2,123 | -8,484 | 33,286 | -10,101 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -31,854 | 1,955 | -8,922 | 32,917 | -10,241 |
| Financing Cash Flow Items | -51.2 | 4,996 | — | -1.02 | 88.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,859 | 6,026 | 48,643 | 5,086 | 22,460 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -43,144 | -12,743 | -258 | 6,240 | -8,446 |